Dianthus Therapeutics, Inc.
DNTHBiotechnology
$82.38−0.39%As of Oct 30vs prior close
- Market cap
- $4.5B
- P/E (TTM)
- –
- From 52W high
- −28.96%
- EPS (LTM)
- -$4.20
- Revenue (LTM)
- $2M
- Net margin
- -7973.33%
- Dividend yield
- 0.00%
Nomior Score
49
Steady ProfileSpeculativeBottom 49% of the scored universe
Growth33
Quality39
Value41
Momentum95
Resilience45
Growth
$2Mrevenue, LTM
YE16 $0LTM $2M
Connections
Revenue to profitQ4 YE25
The operating loss was 24486% of revenue, wider by 22079 pts on a year.
Who owns it
2funds, 1 tracked portfolio